News

After melanoma surgery, hairdresser Carol Helton is spreading the word at her hair salon about staying on top of suspicious moles.

A clinical trial of CAR-T cell therapy developed at Hollings has received NCI funding to expand.

An Ewing sarcoma researcher at MUSC is one of three scientists nationwide to receive a career development award from the Rally Foundation.

Hollings researchers use patented technology to improve immunotherapy by prolonging survival of cancer-fighting T-cells.

Head and neck cancer surgeons at Hollings are testing a fluorescent dye that illuminates nerves, which should make them easier to find during surgery.

Through years of heartache and hard work, widower raises funds for research into the cancer that took his wife.

Working with people with brain tumors brings great satisfaction to South Carolina's only neuro-oncologists.

Two MUSC researchers think that community libraries could hold the potential to improve head and neck cancer awareness.

South Carolinians interested in cancer survivorship - as providers, researchers, caregivers or survivors - are invited to the first SCOR symposium in June.

Meningioma doesn't attract as much research as other types of brain tumors. But Dr. Ben Strickland believes his patients deserve more options.